Investor Database — 54,000+ VC, PE & angel contacts, the full list for $19.Get the list

Kent Life Science (GP) LLP

Private Investment Firm England, United Kingdom ·Founded 2017

Overview

Kent Life Science (GP) LLP is a private investment firm specializing in early-stage investments within the life sciences sector in the United Kingdom. The firm primarily focuses on biotechnology, healthcare, genetics, medical, and therapeutics industries, aiming to support innovative companies in these fields. Established on 11 December 2017, Kent Life Science (GP) LLP is registered at The Business Terrace, King Street, Maidstone, England, ME15 6AW. The firm operates as a limited liability partnership and is active, with its latest annual accounts made up to 31 August 2024. In February 2022, Kent Life Science (GP) LLP invested £32 million in Centauri Therapeutics, a biotechnology company based in England, marking its commitment to advancing early-stage ventures in the life sciences sector. This investment underscores the firm's dedication to fostering growth and innovation within the UK's biotechnology landscape.

Investment Focus

Early-stage life sciences companies in the United Kingdom

Portfolio Companies

Centauri Therapeutics

Reach Kent Life Science (GP) LLP directly

Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.

Unlock full contacts →

Frequently asked questions about Kent Life Science (GP) LLP

What sectors does Kent Life Science (GP) LLP invest in?

Kent Life Science (GP) LLP invests in Healthcare, Biotechnology, Therapeutics, Medical and Genetics, and is based in England, United Kingdom. Kent Life Science (GP) LLP is listed as a private investment firm in the ConnectSafely investor database.